Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Improved Imaging for Neovascular Development in Congenital Heart Disease Research
Published on: April 26, 2024
Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses
Andre B Bautista1, Paul V Suhocki1, Waleska M Pabon-Ramos1
1Division of Vascular and Interventional Radiology, Duke University Medical Center, Box 3808, 2311 Erwin Rd., Durham, NC 27710.
Insights
Endovascular intervention for failing arteriovenous (AV) grafts showed moderate primary patency but good secondary patency. Stenting improved lesion patency, while graft thrombosis and concurrent lesions predicted worse outcomes.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Nephrology
Background:
- Prosthetic arteriovenous (AV) grafts are crucial for hemodialysis access.
- Intragraft stenosis is a common complication leading to graft failure.
- Endovascular intervention is a primary treatment modality for failing AV grafts.
Purpose of the Study:
- To evaluate postintervention patency rates after endovascular treatment of intragraft stenoses in prosthetic AV grafts.
- To identify predictors of patency following these interventions.
Main Methods:
- Retrospective review of 183 patients undergoing percutaneous intervention for first-time intragraft stenoses over 7 years.
- Kaplan-Meier analysis for patency rates and Cox proportional-hazards model for predictors.
- Definition of intragraft stenosis: 2 cm or more from anastomoses.
Main Results:
- 229 intragraft stenoses treated in 183 grafts; 62% presented with graft thrombosis.
- Anatomic success rate of angioplasty was 85%; 15% required stent/stent-graft.
- 6-month primary, secondary, and lesion-specific patency rates were 40%, 77%, and 75%, respectively.
- Graft thrombosis and concurrent nonintragraft lesions were negative predictors of primary patency.
- Stent/stent-graft deployment was a positive predictor of lesion patency.
Conclusions:
- Endovascular intervention for intragraft stenosis yields moderate primary patency but significant secondary patency.
- Stent or stent-graft deployment may enhance lesion patency.
- Graft thrombosis and concurrent lesions negatively impact primary patency outcomes.
Purpose:
To determine postintervention patency rates after endovascular interventions on intragraft stenosis within failing prosthetic arteriovenous (AV) grafts, as well as predictors of patency.
Materials And Methods:
Retrospective review of percutaneous interventions on prosthetic AV grafts presenting with first-time intragraft stenoses over a 7-year period revealed 183 patients (81 male; mean age, 59.7 y). "Intragraft" was defined as 2 cm or more from the arterial or venous anastomosis. Procedural imaging was retrospectively reviewed. Patency rates were estimated by Kaplan-Meier test. Predictors of patency were calculated by Cox proportional-hazards model.
Results:
Two-hundred twenty-nine intragraft stenoses were identified in 183 grafts. Intragraft stenoses were treated at a median of 20.7 months (interquartile range, 12.0-33.9 mo) after graft creation. Graft thrombosis was present in 62%. The anatomic success rate of angioplasty was 85%. Fifteen percent required stent or stent-graft deployment because of inadequate response to angioplasty. A concurrent nonintragraft stenosis within the access circuit was identified in 76% of grafts. At 3, 6, and 12 months, postintervention primary patency rates were 56%, 40%, and 23%, respectively. Secondary patency rates were 84%, 77%, and 67%, respectively. The lesion-specific patency rates were 89, 75%, and 63%, respectively. Graft thrombosis (hazard ratio [HR], 1.43; P = .048) and concurrent nonintragraft lesion (HR, 1.51; P = .047) were independent negative predictors of primary patency. Graft thrombosis (HR, 1.81; P = .029) was a negative predictor of lesion patency, and stent or stent-graft deployment (HR, 0.42; P = .045) was a positive predictor of lesion patency.
Conclusions:
Endovascular interventions on intragraft stenoses resulted in primary, secondary, and lesion-specific patency rates of 40%, 77%, and 75%, respectively, at 6 months. Stent or stent-graft deployment may prolong lesion patency.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Hemodialysis I: Introduction

